Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R21)

The summary for the Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R21): -The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications to understand how endogenous pancreatic beta cells are made by studying pancreatic development, with the goal of making pancreatic islets in culture, to explore the potential of animal or human stem/progenitor cells (embryonic or adult; if human embryonic, only NIH approved human embryonic stem cell lines may be used) as a source for making pancreatic islets, and to determine the basic mechanisms underlying beta cell regeneration in the adult as a basis for producing new cellular therapies for diabetes. This funding opportunity announcement (FOA) is intended to stimulate the application of advances made in developmental biology, stem cell biology, and diabetes to develop new strategies for diabetes therapy, either through cell replacement or regeneration. This FOA is intended to intensify investigator-initiated research, to attract new investigators to the field, and to encourage interdisciplinary approaches to research in this area. -This FOA will utilize the Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-06-271, that solicits applications under the R01 grant mechanism. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. -Eligible organizations: For profit and non-profit organizations, including public or private institutions, units of state and local governments, eligible agencies of the federal government, domestic or foreign institutions/organizations, faith-based or community-based organizations, and units of State and Local Tribal governments. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skill, knowledge and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. -Applicants may submit more than one application, provided they are scientifically distinct.
Federal Grant Title: Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-272
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 24, 2006
Creation Date: Nov 09, 2006
Archive Date: Dec 15, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education County governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-assoc...
Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Kn...
NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Me...
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Met...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com